GLS and colonic neoplasm: The silencing of glutaminase through promoter hypermethylation has been confirmed in colon cancer (67), and if such an effect occurs in response to dietary methyl-donors (e.g., Met, choline, and vitamin B12) it may alter the ability of this enzyme, which is abundant in gut intestinal cells, to utilize glutamine to generate glutamate (68).